CYTOVATION ASA: årsregnskap 2023 vs 2022
Stronger earnings
approved 2024-05-30; registry 2024-08-07; journal 2024 719425
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for CYTOVATION ASA. Net result -122.91m NOK → -81.51m NOK. Equity 51.08m NOK → -30.44m NOK.
On the constructive side: operating result improved; net result improved. Pressures included: equity eroded; cash fell.
Also worth watching: thin equity buffer; paid-in equity reduced. All figures are taken from the published annual accounts for CYTOVATION ASA.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result -122.06m NOK → -77.25m NOK. Calculated
-
↑
Net result improved
Net result -122.91m NOK → -81.51m NOK. Calculated
What deteriorated
-
↓
Equity eroded
Book equity 51.08m NOK → -30.44m NOK (equity ratio 60.9% → -38.9%). Calculated
-
↓
Cash fell
Bank deposits 78.97m NOK → 70.21m NOK (-11.1% YoY). Calculated
Things to notice
-
·
Thin equity buffer
Equity ratio is -38.9% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation
-
·
Paid-in equity reduced
Paid-in equity fell 51.08m NOK → 1.21m NOK — check capital reduction, conversion, or reclassification. Interpretation